Mounjaro Refer a Friend Schemes: The Truth Behind the Offer

The misconception: referral schemes for Mounjaro are just normal marketing

It's easy to assume that refer-a-friend promotions are a routine part of any subscription service. For most consumer products, they are. Mounjaro is not a consumer product. It is a Prescription-Only Medicine regulated under the Human Medicines Regulations 2012, and the MHRA is explicit that GLP-1 weight-loss medicines are not assessed for quick or cosmetic purposes, advertising them to the public is prohibited.

That prohibition extends to incentive schemes. Offering someone credit, cashback or a free pen in exchange for recommending Mounjaro to a friend constitutes promoting a POM to the public, precisely what UK law prevents. It doesn't matter whether the scheme is called a referral bonus, a loyalty reward or an ambassador programme. If the incentive is tied to a prescription medicine, it falls outside what a legitimate, regulated service can offer.

The practical consequence is important: if you find a Mounjaro provider running a refer-a-friend scheme with medicine rewards, that is a compliance signal worth taking seriously. It may indicate the provider is not operating within GPhC pharmacy standards or MHRA advertising rules, and sellers who cut corners on advertising rules often cut corners elsewhere. The MHRA has warned publicly about illegally sold weight-loss pens, and large quantities of counterfeit tirzepatide have been seized in the UK. If you want to check any online pharmacy's legitimacy, you can verify it directly on the GPhC pharmacy register.

What can a Mounjaro provider legitimately offer?

A regulated UK pharmacy or prescribing service can compete on service quality, clinical standards and transparency, not on medicine discounts. That shapes exactly how nume is designed. There are no referral rewards, no discount codes and no promotional pricing attached to the prescription. What is included in a single transparent price is: your consultation, the clinical review by a GPhC-registered Independent Prescriber, the prescription, the treatment itself, and free next-working-day tracked delivery by DPD.

The prescriber side matters here. Every consultation at nume is reviewed by a real clinician, someone reads your answers, checks your health history, and makes a professional judgement about suitability. That review happens the same day you submit. A question our prescribers hear most weeks is whether someone can jump straight to a higher dose to save money. The short answer is no: the starting dose exists to let your body settle into treatment, and titration is a clinical decision, not a commercial one.

If you are already receiving treatment elsewhere and want to transfer, the process is straightforward. Our prescribers review evidence of your current treatment before any dose is continued or changed. You can read about how the consultation works on the Mounjaro without a GP referral page, a private route means no waiting list and no need for a referral letter, but it does not mean bypassing clinical assessment.

For those curious about how private treatment costs compare to what is (or is not) available on the NHS, the Mounjaro pricing page sets out the honest picture, including what to watch for when comparing quotes between providers.

What to do if a friend wants to start Mounjaro

If someone you know is considering Mounjaro, the right thing to do is point them toward a consultation with a regulated service, not hand them a referral link. That distinction matters more than it might sound. A friend starting treatment still needs their own clinical assessment: their BMI, medical history, any concurrent medicines and their individual health picture are all part of the prescriber's decision. What works well for you may not be clinically appropriate for them, and a good prescriber will tell them that honestly.

The licensed eligibility criteria for private treatment are adults with a BMI of 30 or above, or 27 or above where at least one weight-related condition is present. Lower thresholds apply for some ethnic backgrounds under UK guidance. BMI is a starting point, not a guarantee: the prescriber weighs the whole picture, including any contraindications. Tirzepatide carries a Black Triangle (▼) designation, meaning it is under additional MHRA monitoring, something worth mentioning if a friend is nervous about a newer medicine.

Preparing for a first consultation is simpler than most people expect. The treatment page explains exactly what the process involves. And if your friend is still at the research stage, the weight-loss overview gives a balanced look at the options available. Some people also find it helpful to look at the tirzepatide page for the clinical detail behind how the medicine works, or to check the FAQs for practical questions they haven't yet thought to ask. If anything specific comes up, the contact page is the quickest route to the clinical team. You can also read about who leads the clinical review on the clinical team profile.

One practical note: if your friend decides to proceed and orders by midday on a working day, treatment (once approved as clinically suitable) is dispatched the same afternoon. The pen arrives the next working day, in plain unbranded packaging, tracked on their phone via DPD. That kind of reliability is what a regulated service should offer. It's worth more than a referral bonus.

For recipe ideas once treatment is under way, the Mounjaro-friendly recipe suggestions are a useful practical resource, particularly in the early weeks when appetite changes make portion planning feel unfamiliar. If your friend is timing their start around upcoming seasonal promotions, it is also worth checking the Mounjaro Black Friday page to understand what a regulated provider can and cannot legitimately discount.